BioElectronics and SAY-GIN sign agreement to sell ActiPatch and Allay products in Turkey

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable, drug-free anti-inflammatory devices, today announced it has reached an agreement with SAY-GIN Ozel Egtim Yayincilik Ticaret Hizmetleri (SAY-GIN) for distribution of its ActiPatch and Allay products in Turkey.

“We are very excited about expanding into Turkey and are looking forward to working with SAY-GIN”

SAY-GIN has already committed to orders totaling more than $1 million USD in 2010. SAY-GIN is launching a direct response television campaign in Turkey to support sales of both the ActiPatch and Allay product lines.

“We are very excited about expanding into Turkey and are looking forward to working with SAY-GIN,” said BioElectronics Vice President Sales and Marketing, Arnon Horev. “Turkey has the 15^th largest gross domestic product, putting it in the same neighborhood as Canada (14th) and Mexico (11th), and entering this gateway market is important accomplishment for our international expansion.

“With SAY-GIN’s commitment to orders in 2010, it is clear that their consumers are highly receptive to our drug-free pain relieving and healing technology and we believe that will continue to be true as we expand into new markets and build our international presence. We will continue to aggressively move into international markets, with major initiatives already underway in Latin America, China, Japan and Europe. Our partnership with SAY-GIN will help to ensure our international efforts continue to be successful.”